• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Denis Chem Lab Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 13342.0
  • ISIN : INE051G01012
100.10 2 (1.78%)
  • As on 11 Jul 2025 (EOD)

  • Today’s Low

    98.30

  • Today’s High

    101.50

  • Open

    99.90

  • Perv Close

    98.35

  • 52W Low

    87.99

  • 52W High

    204.00

Key Indicators

  • P/E(TTM)

    17.20

  • Mar.Cap (₹Cr.)

    138.91

  • Div & Yield %

    1.50

  • Book Value(₹)

    61.33

  • Debt-Equity Ratio

    1.78

  • AGM Date

    11-Jul-2025

  • EPS

    5.82

  • P/E Ratio

    17.20

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    138.91

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.88

  • BV (₹)

    61.30

  • Sales( ₹ in Cr.)

    173.30

  • NP (in Cr.)

    8.08

  • NP Var(%)

    -28.0

  • Div%

    15.0

  • CPS (₹)

    10.80

  • EPS (₹)

    5.80

  • Traded Value (₹ in Lakhs)

    138.91

  • 52 Week High

    204.00

  • 52 Week Low

    87.99

  • Price BSE

    100.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    138.91

  • P/C Ratio

    9.30

  • P/E Ratio

    17.20

  • Price Vs.BV

    5.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 167.82 160.85 136.56 109.32 136.15 124.14
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 167.82 160.85 136.56 109.32 136.15 124.14
Other Income 1.39 0.59 1.05 0.35 0.28 1.66
Stock Adjustments 1.01 -1.05 -0.03 0.36 1.31 -0.36
Total Income 170.22 160.39 137.58 110.03 137.74 125.44
EXPENDITURE :            
Raw Materials 87.88 83.41 72.32 55.80 62.88 60.82
Power and Fuel Cost 10.59 10.02 8.73 7.22 9.56 8.39
Employee Cost 14.39 13.03 11.74 10.59 12.20 12.46
Other Manufacturing Expenses 4.52 4.88 3.27 2.85 4.54 2.76
Selling and Administration Expenses 26.46 24.99 22.79 19.20 32.02 24.07
Miscellaneous Expenses 3.76 4.70 3.33 3.77 1.26 1.40
Employee Benefit Expenses 14.39 13.03 11.74 10.59 12.20 12.46
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 147.61 141.02 122.18 99.43 122.46 109.89
Operating Profit 22.62 19.37 15.40 10.60 15.28 15.53
Interest 0.54 0.64 0.76 1.55 2.89 3.25
Gross Profit 22.08 18.73 14.64 9.05 12.39 12.28
Depreciation 6.95 7.82 5.76 5.96 6.66 6.36
Profit Before Tax 15.13 10.91 8.88 3.09 5.73 5.92
Current Tax 4.87 3.65 2.15 1.17 1.22 1.29
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.89 -0.60 0.47 -0.34 0.29 -1.72
Reported Net Profit 11.16 7.86 6.26 2.26 4.21 6.35
Extraordinary Items 0.00 0.00 0.02 0.00 0.00 0.81
Adjusted Net Profit 11.16 7.86 6.24 2.26 4.21 5.54
Adjustment below Net Profit -0.28 0.03 -0.28 0.15 -0.20 0.17
P & L Balance brought forward 26.19 20.38 15.43 13.01 10.38 3.86
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.78 2.08 1.04 0.00 1.39 0.00
P & L Balance carried down 34.29 26.19 20.38 15.43 13.01 10.38
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 25.00 20.00 15.00 7.50 0.00 10.00
Dividend Per Share(Rs) 2.50 2.00 1.50 0.75 0.00 1.00
Earnings Per Share-Unit Curr 8.04 5.66 4.51 1.63 3.04 4.58
Earnings Per Share(Adj)-Unit Curr 8.04 5.66 4.51 1.63 3.04 4.58
Book Value 57.91 52.08 47.89 44.32 42.58 40.69
Book Value(Adj)-Unit Curr 57.91 52.08 47.89 44.32 42.58 40.69

Shareholding Pattern

  • Promoter Group

    38.98%

  • Public Share Holding

    61.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,409,237 38.98 5,409,237 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,409,237 38.98 5,409,237 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,493,061 10.76 1,493,061 25
Clearing Members 6 0.00 6 1
Directors of their Relatives 62,656 0.45 62,656 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 78,832 0.57 78,632 98
Foreign Non Institution Other 2,877,774 20.74 2,877,774 1
Hindu Undivided Families 141,864 1.02 141,864 201
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,418,837 10.22 1,418,837 4
Individuals holding nominal share capital up to Rs. 1 lakh 2,385,216 17.19 2,176,297 6,878
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 274 0.00 224 2
Sub Total 8,467,431 61.02 8,258,262 7,215
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,876,668 100.00 13,667,499 7,218

Company Background

Denis Chem Lab LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Denis Chem Lab Ltd
  • BSE Code : 13342.0
  • ISIN : INE051G01012

  • Incorporation Year

    1980

  • Registered Office

    Block No 457 Kalol Taluka
    Chhatral, Gandhinagar,
    Gujarat-382729

  • Telephone

    91-2764-233596/233613

  • FAX

    91-2764-233896

  • Chairman

    Dinesh B Patel

  • Managing Director

    Himanshu C Patel

  • Company Secretary

    Anal Desai

  • Auditor

    Shah & Shah Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-1 Off C.G Road ,Ellisbridge
    Mumbai - Ahmedabad-380006

Denis Chem Lab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Denis Chem Lab 100.10 169.21 167.82 17.20 20.07
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10